Clinical Trial

HALO-TRIAL: High, Medium And LOw Intensity Psychotherapy for Binge Eating Disorder

Study acronym: HALO
Recruiting
View on ClinicalTrials.gov →
Summary
The HALO trial is designed as a four-armed, assessor-blinded, fidelity-monitored randomized clinical trial. The goal of this randomized controlled study is to investigate the effectiveness of four different psychotherapy programs and to determine which one is most effective in reducing the number of binge-eating episodes in people with the eating disorder Binge Eating Disorder (BED), by directly comparing three intensities of Cognitive Behavioral Therapy-Enhanced against a manualized treatment as usual. Participants will be asked to complete a 21-weeks randomized intervention and participate in follow up assesments.
Trial Details
NCT Number NCT07698132
Lead Sponsor Herlev and Gentofte Hospital
Collaborators: Jascha Fonden, BETA-HEALTH Foundation, Mental Health Centre Ballerup, Region Capital Denmark, University of Copenhagen
Conditions Binge Eating Disorder, Binge Eating Episodes, Binge Eating/Loss of Control Eating, Binge Eating Disorders, Binge Eating, Binge Eating Behaviour, Binge Eating Disorder Associated With Obesity, Eating Disorder Binge +1 more
Enrollment 256 participants
Start Date 2024-06-10
Primary Completion 2032-12 (estimated)
Study Completion 2032-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-13